emrosi journey medical news

FDA approves Journey Medical’s rosacea treatment Emrosi

The US’ Food and Drug Administration (FDA) has approved Journey Medical’s Emrosi, the brand name for its 40mg minocycline hydrochloride extended-release capsules, to be used in the treatment of dermatological condition rosacea.

Reuters on MSN · 1d

US FDA approves Journey Medical's drug for long-term skin condition

The U.S. Food and Drug Administration has approved Journey Medical's drug for the treatment of a long-term skin condition called rosacea, the company said on Monday.

Business Insider · 1d

Journey Medical announces U.S. FDA approval of Emrosi

Journey Medical (DERM) announced that the FDA has approved Emrosi, formerly referred to as DFD-29, for the treatment of inflammatory lesions of

Seeking Alpha · 1d

Journey gets FDA okay for Emrosi, releases preliminary Q3 earnings report

Journey Medical (DERM) received FDA approval for its drug Emrosi for the treatment of rosacea and released its preliminary Q3 earnings report. Read more here.

Fortress Biotech’s Majority-Controlled Subsidiary, Journey Medical Corporation, Receives FDA Approval for Emrosi™ for Rosacea Treatment

Fortress Biotech, Inc. (NASDAQ: FBIO) announced through its majority-controlled subsidiary, Journey Medical Corporation, that the U.S. Food and Drug Administration (FDA) has approved Emrosi™ ...

1don MSN

What's Going On With Journey Medical Stock Today?

Journey Medical (NASDAQ:DERM) shares are trading higher Monday after the company announced the U.S. Food and Drug ...

Morningstar19d

Journey Medical Corp DERM

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Nasdaq11d

Journey Medical announces presentation of DFD-29 data

Journey Medical (DERM) presented data assessing the dermal and systemic pharmacokinetics of oral DFD-29 versus oral Doxycycline 40 mg capsules in healthy subjects at the 44th Fall Clinical ...

Yahoo Finance12d

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

SCOTTSDALE, Ariz., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that primarily focuses on selling ...

USA Today12d

Travel medical insurance 2024: Your emergency coverage policy

Please view our full advertiser disclosure policy. Travel medical insurance pays for emergency medical expenses if you get sick or injured while on a trip. This coverage is especially important if ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results